Newborn screening platform for lysosomal storage disorders with FDA clearance and CE mark

SEEKER is a high throughput laboratory solution that quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of:

Mucopolysaccharidosis Type I (MPS I), Pompe, Gaucher or Fabry disease

Everything your lab needs for LSD screening in one small workstation

SEEKER Features:

  • Flexible
  • Cost-effective
  • Fast results
  • Simple operation

 

SEEKER Brochure

Powered by digital microfluidics technology, Baebies SEEKER provides newborn screening results in under 3 hours for multiple LSDs from a single DBS punch. SEEKER’s first tier enzymatic assay results can be paired with second tier genetic sequencing to reduce false positives, preventing unnecessary family anxiety.

Contact us today for more information and to discuss your customized lab needs.

 

Request for Demo